Prozkoumejte nejčtenější články a videa na Campus Sanofi
Early identification of autoantibodies can help predict T1D development before symptoms appear.
Type 1 diabetes progresses from presymptomatic autoimmunity to symptomatic hyperglycemia, ultimately requiring lifelong insulin therapy. DKA can cause severe metabolic imbalances requiring hospitalization, significantly disrupting daily life and posing serious health risks.
Screening for individuals with first-degree relatives with T1D, particularly those with high-risk and Regular monitoring of autoantibodies and glucose tolerance can facilitate earlier diagnosis and treatment initiation.
Expert thoughts on the rising prevalence of Type 1 Diabetes and its implications for public health. Type 1 diabetes represents few diabetes cases globally, creating both physical and psychological challenges.